-
Combating depressed trading on the LSE and a delayed hard market shift has held back the firm. -
From where to prioritise investing to managing slower growth, there are tough balancing acts ahead.
-
The investment recovery will be welcome but Chinese tariffs will contribute to loss-cost inflation.
-
The IGH closure is bitter for employee investors left with nothing – but such investments are inherently risky.
-
Lloyd’s has been likened to a “toothless tiger” in its crackdown efforts.
-
An issue has emerged in diligence, and Howden has a complex consortium to align.
-
Technological delays erode credibility, but the market remains strong.
-
Lloyd’s hopes to protect healthy pricing, but focus is on broader structural market shifts.
-
Island appetite remains stable, but early 2025 loss activity has injected fresh uncertainty.
-
Navigating its path to global specialty growth will require operational dexterity.
-
PIB’s broadened sale process is symptomatic of wider investor sentiment around brokers.
-
Lloyd’s entry is a modest start for the London heavyweight but could be the beginning of something bigger.
